Buy Day today: Neutral (53) Mixed market breadth · no major macro event

Sana Biotechnology Inc (SANA)

Healthcare Biotechnology —

3.10 $

-3.7% vs. previous close

Closing price · As of: 31. Jul 2026

Sana Biotechnology Inc (SANA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Total Assets" came in at 374 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow

Annual Quarterly

All figures in millions of USD.

Balance Sheet SANA
Tick rows to compare them in a chart (up to 4)	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26
Total Assets	707	631	565	681	619	559	501	445	362	435	417	374
Current Assets	339	280	214	321	263	210	161	113	83	162	149	112
Cash	174	168	134	177	135	127	128	96	71	103	72	84
Cash & Short-Term Investments	326	269	205	311	252	199	152	105	73	153	138	101
Property, Plant & Equipment	157	–	–	–	–	–	–	–	–	–	–	–
Goodwill	141	141	141	141	141	141	141	141	141	141	141	141
Intangible Assets	59	59	59	59	59	59	59	59	59	59	59	59
Total Liabilities	352	266	278	306	279	267	251	236	239	240	256	254
Current Liabilities	112	67	64	53	51	47	45	33	33	36	79	86
Short-Term Debt	13	13	13	13	10.0	11	13	13	14	15	15	15
Accounts Payable	3.1	9.9	4.1	6.1	3.8	3.0	5.2	1.0	2.3	1.9	1.7	2.1
Shareholders' Equity	355	366	288	375	340	292	251	209	123	195	161	119
Retained Earnings	-1,251	-1,250	-1,338	-1,446	-1,496	-1,556	-1,605	-1,654	-1,748	-1,790	-1,849	-1,896
Shares Outstanding	193	200	197	217	234	235	236	238	238	260	253	277

Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Cookie settings